Exclusive: Google DeepMind researcher David Silver leaves to launch his own AI startup
David Silver, a well-known Google DeepMind researcher who played a critical role in many of the company’s most…
The pioneer behind Google Gemini is tackling an even bigger challenge—using AI to ‘solve’ disease
The astonishingly prodigious child of bohemian parents, Hassabis grew up in North London in the 1980s. And through…
Apple, Google strike Gemini deal for revamped Siri in major win for Alphabet
Jan 12 (Reuters) – Apple will use Google’s Gemini models for its revamped Siri coming later this year…
Alphabet Ramps Up AI Chip Patents to Curb Nvidia Dependence
This article first appeared on GuruFocus. Alphabet (GOOGL, Financials) is increasing AI hardware investment. In order to reduce…
New York to require social media platforms to display mental health warnings
Social media platforms with infinite scrolling, auto-play and algorithmic feeds will be required to display warning labels about…
Alphabet Poised for Another Paper Gain as SpaceX Valuation Jumps
(Bloomberg) — Alphabet Inc. is set to book another sizable paper gain after SpaceX completes a tender offer…
Move Over D-Wave, Alphabet Is Taking Over Quantum Computing
D-Wave’s status as pure-play in quantum computing could help deliver big upside, but Alphabet offers a more balanced…
OpenAI goes from stock market savior to burden as AI risks mount
Wall Street’s sentiment toward companies associated with artificial intelligence is shifting, and it’s all about two companies: OpenAI…
As AI wipes jobs, Google CEO Sundar Pichai says it’s up to everyday people to adapt accordingly
Tech leaders are split on whether AI will bring about a jobs Armageddon or a utopia of zero…
Google DeepMind’s AlphaFold shows why science may be AI’s killer app
While many businesses continue to seek AI’s killer app, biochemists have already found it. That application is protein…
Alphabet Stock Hits Record Peak After Report Meta Aims to Buy Google’s TPU Chips
This article first appeared on GuruFocus. Alphabet (NASDAQ:GOOGL) shares rose about 2%, hitting a second all-time high at…
AbbVie parts ways with Calico
Unexpected uncoupling raises questions about the pace – and patience – of longevity drug discovery amid shifting pharma…